Tracking the CYTK option chain helps you see every strike and expiry on Cytokinetics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Cytokinetics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CYTK options activity at a glance. Use our scanner to monitor the CYTK option chain in real time and filter for the CYTK options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CYTK stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CYTK option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CYTK stock options are being actively traded and where they are not.
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy.
The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy; and CK-3772271, a small molecule cardiac myosin inhibitor that is in Phase I clinical trial. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Cytokinetics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CYTK options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CYTK stock options — let the full option chain come to you, pre-filtered and ready to trade.
